Price Alert

LifeStance Health Group I... (LFST)

NASDAQ: LFST · Real-Time Price · USD

5.58

0.41 (7.93%)

At close: Aug 14, 2025, 3:59 PM

5.58

0.00%

Pre-market: Aug 15, 2025, 08:45 AM EDT

LifeStance Health Statistics

Share Statistics

LifeStance Health has 388.88M shares outstanding. The number of shares has increased by 1.63% in one year.

Shares Outstanding	388.88M
Shares Change (YoY)	1.63%
Shares Change (QoQ)	1.12%
Owned by Institutions (%)	89.57%
Shares Floating	128.56M
Failed to Deliver (FTD) Shares	11,114
FTD / Avg. Volume	0.49%

Short Selling Information

The latest short interest is 8M, so 2.06% of the outstanding shares have been sold short.

Short Interest	8M
Short % of Shares Out	2.06%
Short % of Float	9.28%
Short Ratio (days to cover)	3.28

Valuation Ratios

The PE ratio is -48.64 and the forward PE ratio is 87.1. LifeStance Health's PEG ratio is 0.69.

PE Ratio	-48.64
Forward PE	87.1
PS Ratio	2.23
Forward PS	1.1
PB Ratio	1.93
P/FCF Ratio	32.61
PEG Ratio	0.69

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for LifeStance Health.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.34.

Current Ratio	1.37
Quick Ratio	1.37
Debt / Equity	0.34
Debt / EBITDA	12.17
Debt / FCF	5.66
Interest Coverage	-1.19

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$166.02K
Profits Per Employee	$-7.62K
Employee Count	7,535
Asset Turnover	0.59
Inventory Turnover	n/a

Taxes

Income Tax	-170K
Effective Tax Rate	0.3%

Stock Price Statistics

The stock price has increased by -16.73% in the last 52 weeks. The beta is 1.13, so LifeStance Health's price volatility has been higher than the market average.

Beta	1.13
52-Week Price Change	-16.73%
50-Day Moving Average	4.82
200-Day Moving Average	6.55
Relative Strength Index (RSI)	51.31
Average Volume (20 Days)	2,283,137

Income Statement

In the last 12 months, LifeStance Health had revenue of 1.25B and earned -57.44M in profits. Earnings per share was -0.15.

Revenue	1.25B
Gross Profit	402.4M
Operating Income	-31.61M
Net Income	-57.44M
EBITDA	39.87M
EBIT	-31.08M
Earnings Per Share (EPS)	-0.15

Full Income Statement

Balance Sheet

The company has 154.57M in cash and 485.19M in debt, giving a net cash position of -330.62M.

Cash & Cash Equivalents	154.57M
Total Debt	485.19M
Net Cash	-330.62M
Retained Earnings	-818.29M
Total Assets	2.15B
Working Capital	116.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 107.26M and capital expenditures -21.57M, giving a free cash flow of 85.69M.

Operating Cash Flow	107.26M
Capital Expenditures	-21.57M
Free Cash Flow	85.69M
FCF Per Share	0.23

Full Cash Flow Statement

Margins

Gross margin is 32.17%, with operating and profit margins of -2.53% and -4.59%.

Gross Margin	32.17%
Operating Margin	-2.53%
Pretax Margin	-4.61%
Profit Margin	-4.59%
EBITDA Margin	3.19%
EBIT Margin	-2.53%
FCF Margin	6.85%

Dividends & Yields

LFST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for LFST is $9, which is 96.5% higher than the current price. The consensus rating is "Buy".

Price Target	$9
Price Target Difference	96.5%
Analyst Consensus	Buy
Analyst Count	5

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	1.64
Piotroski F-Score	5